In the last three years, the confluence of digital health and the “Internet of Things” (IoT) technology markets have simultaneously reached a fevered pitch. As with many new technology markets, however, this new sector’s success depends on the ability of emerging companies to leverage a well-developed ecosystem. One key component of such an ecosystem is often the existence of a “nexus point facility” dedicated to helping people trying to design, build and collaborate to create future products.
In the Portland metro area, the digital health and Internet of Things sectors have attracted growing investor and stakeholder interest. Unfortunately, there is currently no facility equipped and managed to provide the design, production, testing, and support services infrastructure to support this growing sector.

Creating a Digital Health Nexus Point
Our strategy is to create the Digital Health Collaborative (DHC), working with other partners, as the innovation hub and makers space for digital health and IoT markets. The logic of locating such a facility in Beaverton stems for this region’s unique geographic position including close proximity to light rail, OHSU, Welch Allyn, BIOTRONIK, Nike and Intel. The location leverages Beaverton’s long history of supporting the microelectronics and software industries–key ingredients for successful digital health collaborations. The DHC would offer the following resources/services:

  • Industry and technical mentoring
  • Specialized equipment
  • Limited office space/conference rooms
  • Testing center (phones, handhelds, development software, etc.)
  • Technology education programs
  • Events and hosting space
  • Access to server/cloud services
  • Video conferencing
  • Prototyping tools (3D printers, etc.)

Our goal, and a key measure of success, will be our ability to attract the support of more established healthcare and technology companies. As an industry-driven collaborative, its impact will depend on the industry support it can generate. The overall emphasis is to create a facility driven by the success of the tenants and partners.

Benefits to the Region
In the 70’s and 80’s Beaverton was synonymous with technology innovation (Tektronix, Floating Point, etc.). The HDC has the potential to revive this history and become the nexus point for “Internet of Medical Things” companies in Oregon. By leveraging and capitalizing on this, the DHC can generate the following regional benefits:

  • Networking opportunities for technology leaders
  • Partnering discussions with health system partners
  • Expanded learning opportunities
  • Act as technology hub to link partners and sponsors
  • Support local digital health leaders (Welch Allyn, TE Connectivity, Biotronik, etc.)
  • Exposure to largest technology companies (Intel, Amazon, Microsoft, HP, Google, etc.)
  • Generate significant economic development and PR for region

Founding Companies / Management Partners

Digital Health CollaborativeCuradite is a medication adherence company dedicated to helping patient, caregivers and the healthcare community improve patient outcomes. By leveraging the latest Internet of Things technology advances to provide a seamless system to for managing a patient’s medication regimen, Curadite provides a unique solution that combines intelligent packaging, real-time dashboards, helpful education and personal mentoring. At Curadite we believe you should not worry when someone you love forgets

Dennis McNannay, CEO, [email protected]

HealthSaasHealthSaaS is an innovative leader in healthcare interoperability solutions that enable meaningful exchange of patient-driven data. Our cloud‐based IoT services provide health IT companies, clinicians, hospitals, pharmacies and home health organizations with a secure, vendor‐neutral infrastructure that provides just in time data to facilitate early interventions and reduce readmissions for chronic condition patients. HealthSaaS provides easy to use telehealth connectivity solutions for patients who have diabetes, hypertension, heart failure, atrial fibrillation, COPD and asthma.

Frank Ille, CEO, [email protected]